LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 8.76 | 27.76 | 789 | 401 | 1.9669 | 1.3838 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 8.76 | 27.76 | 883 | 401 | 2.2012 | 1.4545 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 10.46 | 27.76 | 816 | 438 | 1.8603 | 1.3374 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 10.46 | 27.76 | 3 | 438 | 0.0068 | -0.4281 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 10.46 | 27.76 | 885 | 438 | 2.0176 | 1.3855 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.17 | 27.76 | 10 | 489 | 0.0204 | -0.2186 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.17 | 27.76 | 883 | 489 | 1.8055 | 1.3069 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.17 | 27.76 | 94 | 489 | 0.1922 | 0.3427 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.17 | 27.76 | 922 | 489 | 1.8852 | 1.3311 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 13.87 | 27.76 | 269 | 604 | 0.4448 | 0.6668 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 13.87 | 27.76 | 879 | 604 | 1.4536 | 1.1756 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 13.87 | 27.76 | 242 | 604 | 0.4002 | 0.6276 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 13.87 | 27.76 | 1018 | 604 | 1.6834 | 1.2486 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 15.58 | 27.76 | 520 | 685 | 0.7585 | 0.8840 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 15.58 | 27.76 | 940 | 685 | 1.3711 | 1.1412 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 15.58 | 27.76 | 445 | 685 | 0.6491 | 0.8216 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 15.58 | 27.76 | 1007 | 685 | 1.4688 | 1.1733 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.28 | 27.76 | 780 | 838 | 0.9300 | 0.9707 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.28 | 27.76 | 920 | 838 | 1.0969 | 1.0380 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.28 | 27.76 | 700 | 838 | 0.8346 | 0.9278 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.28 | 27.76 | 970 | 838 | 1.1565 | 1.0600 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 18.98 | 27.76 | 872 | 941 | 0.9265 | 0.9702 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 18.98 | 27.76 | 936 | 941 | 0.9945 | 0.9979 | MN20160318_Q01 | D06 |